Stealth BioTherapeutics Corp — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2021)

-$52.5M

Total Assets (FY2021)

$50.2M

Total Equity (FY2021)

-$45.3M

Cash Flows from Operating Activities (FY2021)

-$45.0M

Source: Stealth BioTherapeutics Corp 20-F filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.